{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:55:10Z","timestamp":1782489310591,"version":"3.54.5"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.ijpharm.2012.09.051","type":"journal-article","created":{"date-parts":[[2012,10,6]],"date-time":"2012-10-06T15:45:28Z","timestamp":1349538328000},"page":"148-153","source":"Crossref","is-referenced-by-count":65,"title":["Enhancement of corneal permeation of riboflavin-5\u2032-phosphate through vitamin E TPGS: A promising approach in corneal trans-epithelial cross linking treatment"],"prefix":"10.1016","volume":"440","author":[{"given":"Carmine","family":"Ostacolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Tronino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Troisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Laneri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Pacente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Del Prete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Sacchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2012.09.051_bib0005","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jcrs.2009.01.009","article-title":"Corneal crosslinking: riboflavin concentration in corneal stroma exposed with and without epithelium","volume":"35","author":"Baiocchi","year":"2009","journal-title":"J. Cataract Refract. Surg."},{"key":"10.1016\/j.ijpharm.2012.09.051_bib0010","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1755-3768.1986.tb06875.x","article-title":"Ultrastructural changes to corneal stromal cells due to ophthalmic preservatives","volume":"64","author":"Collin","year":"1986","journal-title":"Acta Opthalmol."},{"key":"10.1016\/j.ijpharm.2012.09.051_bib0015","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jconrel.2005.11.005","article-title":"Influence of vitamin E TPGS poly(ethylene glycol) chain length on apical efflux transporters in Caco-2 cell monolayers","volume":"111","author":"Collnot","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.09.051_bib0020","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11095-005-9262-9","article-title":"Advances in the use of tocols as drug delivery vehicles","volume":"23","author":"Constantinides","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2012.09.051_bib0025","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/jps.3030490708","article-title":"Interaction of preservatives with macromolecules IV. Binding of quaternary ammonium compounds by nonionic agents","volume":"49","author":"DeLuca","year":"1960","journal-title":"J. Am. Pharm. Assoc."},{"key":"10.1016\/j.ijpharm.2012.09.051_bib0030","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1442-9071.2010.02228.x","article-title":"Collagen cross-linking: a new treatment paradigm in corneal diseases\u2013a review","volume":"38","author":"Franzco","year":"2010","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.ijpharm.2012.09.051_bib0035","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1097\/ICO.0b013e31820143d1","article-title":"Limitation of collagen cross-linking with hypoosmolar riboflavin solution: failure in an extremely thin cornea","volume":"30","author":"Hafezi","year":"2011","journal-title":"Cornea"},{"key":"10.1016\/j.ijpharm.2012.09.051_bib0040","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1080\/02713680600899655","article-title":"Identification and functional expression of a carrier-mediated riboflavin transport system on rabbit corneal epithelium","volume":"31","author":"Hariharan","year":"2006","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.ijpharm.2012.09.051_bib0045","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.addr.2008.09.002","article-title":"Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery","volume":"60","author":"Jiao","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2012.09.051_bib0050","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1089\/jop.2005.21.275","article-title":"Identification and functional characterization of riboflavin transporter in human-derived retinoblastoma cell line (Y-79): mechanisms of cellular uptake and translocation","volume":"21","author":"Kansara","year":"2005","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ijpharm.2012.09.051_bib0055","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1089\/jop.2006.22.110","article-title":"Modulation of P-glycoprotein-mediated efflux by prodrug derivatization: an approach involving peptide transporter-mediated influx across rabbit cornea","volume":"22","author":"Katragadda","year":"2006","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ijpharm.2012.09.051_bib0060","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3109\/02713683.2010.481068","article-title":"Pharmacological modification of the epithelial permeability by benzalkonium chloride in UVA\/riboflavin corneal collagen cross-linking","volume":"35","author":"Kissner","year":"2010","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.ijpharm.2012.09.051_bib0065","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3109\/02713688509025145","article-title":"Transport processes across the rabbit corneal epithelium: a review","volume":"4","author":"Klyce","year":"1985","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.ijpharm.2012.09.051_bib0070","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jcrs.2005.12.092","article-title":"Biomechanical evidence of the distribution of cross-links in corneas treated with riboflavin and ultraviolet A light","volume":"32","author":"Kohlhaas","year":"2006","journal-title":"J. Cataract Refract. Surg."},{"key":"10.1016\/j.ijpharm.2012.09.051_bib0075","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3928\/1081597X-20090813-11","article-title":"Keratitis and corneal scarring after UVA\/riboflavin cross-linking for keratoconus","volume":"25","author":"Koppen","year":"2009","journal-title":"J. Refract. Surg."},{"key":"10.1016\/j.ijpharm.2012.09.051_bib0080","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0039-6257(84)90094-8","article-title":"Keratoconus and related noninflammatory corneal thinning disorders","volume":"28","author":"Krachmer","year":"1984","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.ijpharm.2012.09.051_bib0085","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3928\/1081597X-20100212-09","article-title":"Transepithelial corneal collagen cross-linking in keratoconus","volume":"26","author":"Leccisotti","year":"2010","journal-title":"J. Refract. Surg."},{"key":"10.1016\/j.ijpharm.2012.09.051_bib0090","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/019262339802600205","article-title":"Ocular irritation: microscopic changes occurring over time in the rat with surfactants of known irritancy","volume":"26","author":"Maurer","year":"1998","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.ijpharm.2012.09.051_bib0095","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00003226-200001000-00019","article-title":"Apoptosis in UV exposed rabbit corneas","volume":"19","author":"Podskochy","year":"2000","journal-title":"Cornea"},{"key":"10.1016\/j.ijpharm.2012.09.051_bib0100","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jcrs.2008.09.029","article-title":"Bacterial keratitis early after corneal crosslinking with riboflavin and ultraviolet-A","volume":"35","author":"Pollhammer","year":"2009","journal-title":"J. Cataract Refract. Surg."},{"key":"10.1016\/j.ijpharm.2012.09.051_bib0105","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ajo.2005.05.029","article-title":"Risk factors for progression to penetrating keratoplasty in patients with keratoconus","volume":"140","author":"Reeves","year":"2005","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ijpharm.2012.09.051_bib0110","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3928\/1081597X-20080601-05","article-title":"Epithelial thickness in the normal cornea: three-dimensional display with Artemis very high-frequency digital ultrasound","volume":"24","author":"Reinstein","year":"2008","journal-title":"J. Refract. Surg."},{"key":"10.1016\/j.ijpharm.2012.09.051_bib0115","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0378-5173(96)04663-7","article-title":"Evaluation of ocular permeation enhancers: in vitro effects on corneal transport of four \u03b2-blockers, and in vitro\/in vivo toxic activity","volume":"142","author":"Saettone","year":"1996","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.09.051_bib0120","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/exer.1997.0410","article-title":"Induction of cross-links in corneal tissue","volume":"66","author":"Spoerl","year":"1998","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ijpharm.2012.09.051_bib0125","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/ajcn\/48.3.605","article-title":"Uptake of intact TPGS (d-alpha-tocopheryl polyethylene glycol 1000 succinate) a water-miscible form of vitamin E by human cells in vitro","volume":"48","author":"Traber","year":"1988","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ijpharm.2012.09.051_bib0130","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1021\/jf030756s","article-title":"Liquid chromatographic analysis of riboflavin vitamers in foods using fluorescence detection","volume":"52","author":"Vi\u00f1as","year":"2004","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ijpharm.2012.09.051_bib0135","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/S0886-3350(03)00407-3","article-title":"Stress\u2013strain measurements of human and porcine corneas after riboflavin\u2013ultraviolet-A-induced cross-linking","volume":"29","author":"Wollensak","year":"2003","journal-title":"J. Cataract Refract. Surg."},{"key":"10.1016\/j.ijpharm.2012.09.051_bib0140","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/S0886-3350(03)00343-2","article-title":"Endothelial cell damage after riboflavin-ultraviolet-A-treatment in the rabbit","volume":"29","author":"Wollensak","year":"2003","journal-title":"J. Cataract Refract. Surg."},{"key":"10.1016\/j.ijpharm.2012.09.051_bib0145","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/01.icu.0000233954.86723.25","article-title":"Crosslinking treatment of progressive keratoconus: new hope","volume":"17","author":"Wollensak","year":"2006","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.ijpharm.2012.09.051_bib0150","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jcrs.2008.11.036","article-title":"Biomechanical and histological changes after corneal crosslinking with and without epithelial debridement","volume":"35","author":"Wollensak","year":"2009","journal-title":"J. Cataract Refract. Surg."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312009362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312009362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T09:04:50Z","timestamp":1562231090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517312009362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0378517312009362"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2012.09.051","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}